Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome

Bone Marrow Transplant. 2017 Jun;52(6):913-914. doi: 10.1038/bmt.2017.25. Epub 2017 Mar 13.

Authors

P Kreetapirom¹, S Hongeng¹, W Manuyakorn¹, U Anurathapan¹, S Pakakasama¹, N Sirachainan¹, B S Andersson²

Affiliations

¹ Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
² Departments of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 28287640
DOI: 10.1038/bmt.2017.25

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Allografts
HLA Antigens*
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Male
Wiskott-Aldrich Syndrome / blood
Wiskott-Aldrich Syndrome / therapy*

Substances

HLA Antigens